Exact Mass: 477.1761
Exact Mass Matches: 477.1761
Found 224 metabolites which its exact mass value is equals to given mass value 477.1761
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Batimastat
Pralatrexate
ritanserin
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Ritanserin (R 55667) is a highly potent, relatively selective, orally active, long acting antagonist of 5-HT2 receptor, with an IC50 of 0.9 nM, less active on Histamine H1, Dopamine D2, Adrenergic α1, Adrenergic α2 receptors[1].
7-hydroxy-1-(3,4-dihydroxy)-N2,N3-bis(4-hydroxyphenethyl)-6,8-dimethoxy-1,2-dihydronaphthalene-2,3-dicarboxamide
Pralatrexate
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BA - Folic acid analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor
Ser Gln Asp Glu
ritanserin
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Ritanserin (R 55667) is a highly potent, relatively selective, orally active, long acting antagonist of 5-HT2 receptor, with an IC50 of 0.9 nM, less active on Histamine H1, Dopamine D2, Adrenergic α1, Adrenergic α2 receptors[1].
Ala Asp Ser Trp
Ala Asp Trp Ser
Ala Ser Asp Trp
Ala Ser Trp Asp
Ala Trp Asp Ser
Ala Trp Ser Asp
Cys Cys Pro Arg
Cys Cys Arg Pro
Cys Met Pro Gln
Cys Met Gln Pro
Cys Pro Cys Arg
Cys Pro Met Gln
Cys Pro Gln Met
Cys Pro Arg Cys
Cys Gln Met Pro
Cys Gln Pro Met
Cys Arg Cys Pro
Cys Arg Pro Cys
Asp Ala Ser Trp
Asp Ala Trp Ser
Asp Asp Gln Thr
Asp Asp Thr Gln
Asp Glu Asn Thr
Asp Glu Gln Ser
Asp Glu Ser Gln
Asp Glu Thr Asn
Asp Gly Thr Trp
Asp Gly Trp Thr
Asp Asn Glu Thr
Asp Asn Thr Glu
Asp Gln Asp Thr
Asp Gln Glu Ser
Asp Gln Ser Glu
Asp Gln Thr Asp
Asp Ser Ala Trp
Asp Ser Glu Gln
Asp Ser Gln Glu
Asp Ser Trp Ala
Asp Thr Asp Gln
Asp Thr Glu Asn
Asp Thr Gly Trp
Asp Thr Asn Glu
Asp Thr Gln Asp
Asp Thr Trp Gly
Asp Trp Ala Ser
Asp Trp Gly Thr
Asp Trp Ser Ala
Asp Trp Thr Gly
Glu Asp Asn Thr
Glu Asp Gln Ser
Glu Asp Ser Gln
Glu Asp Thr Asn
Glu Glu Asn Ser
Glu Glu Ser Asn
Glu Gly Ser Trp
Glu Gly Trp Ser
Glu Asn Asp Thr
Glu Asn Glu Ser
Glu Asn Ser Glu
Glu Asn Thr Asp
Glu Gln Asp Ser
Glu Gln Ser Asp
Glu Ser Asp Gln
Glu Ser Glu Asn
Glu Ser Gly Trp
Glu Ser Asn Glu
Glu Ser Gln Asp
Glu Ser Trp Gly
Glu Thr Asp Asn
Glu Thr Asn Asp
Glu Trp Gly Ser
Glu Trp Ser Gly
Gly Asp Thr Trp
Gly Asp Trp Thr
Gly Glu Ser Trp
Gly Glu Trp Ser
Gly Ser Glu Trp
Gly Ser Trp Glu
Gly Thr Asp Trp
Gly Thr Trp Asp
Gly Trp Asp Thr
Gly Trp Glu Ser
Gly Trp Ser Glu
Gly Trp Thr Asp
Met Cys Pro Gln
Met Cys Gln Pro
Met Pro Cys Gln
Met Pro Gln Cys
Met Gln Cys Pro
Met Gln Pro Cys
Asn Asp Glu Thr
Asn Asp Thr Glu
Asn Glu Asp Thr
Asn Glu Glu Ser
Asn Glu Ser Glu
Asn Glu Thr Asp
Asn Ser Glu Glu
Asn Thr Asp Glu
Asn Thr Glu Asp
Pro Cys Cys Arg
Pro Cys Met Gln
Pro Cys Gln Met
Pro Cys Arg Cys
Pro Met Cys Gln
Pro Met Gln Cys
Pro Gln Cys Met
Pro Gln Met Cys
Pro Arg Cys Cys
Gln Cys Met Pro
Gln Cys Pro Met
Gln Asp Asp Thr
Gln Asp Glu Ser
Gln Asp Ser Glu
Gln Asp Thr Asp
Gln Glu Asp Ser
Gln Glu Ser Asp
Gln Met Cys Pro
Gln Met Pro Cys
Gln Pro Cys Met
Gln Pro Met Cys
Gln Ser Asp Glu
Gln Ser Glu Asp
Gln Thr Asp Asp
Arg Cys Cys Pro
Arg Cys Pro Cys
Arg Pro Cys Cys
Ser Ala Asp Trp
Ser Ala Trp Asp
Ser Asp Ala Trp
Ser Asp Glu Gln
Ser Asp Gln Glu
Ser Asp Trp Ala
Ser Glu Asp Gln
Ser Glu Glu Asn
Ser Glu Gly Trp
Ser Glu Asn Glu
Ser Glu Gln Asp
Ser Glu Trp Gly
Ser Gly Glu Trp
Ser Gly Trp Glu
Ser Asn Glu Glu
Ser Gln Glu Asp
Ser Trp Ala Asp
Ser Trp Asp Ala
Ser Trp Glu Gly
Ser Trp Gly Glu
Thr Asp Asp Gln
Thr Asp Glu Asn
Thr Asp Gly Trp
Thr Asp Asn Glu
Thr Asp Gln Asp
Thr Asp Trp Gly
Thr Glu Asp Asn
Thr Glu Asn Asp
Thr Gly Asp Trp
Thr Gly Trp Asp
Thr Asn Asp Glu
Thr Asn Glu Asp
Thr Gln Asp Asp
Thr Trp Asp Gly
Thr Trp Gly Asp
Trp Ala Asp Ser
Trp Ala Ser Asp
Trp Asp Ala Ser
Trp Asp Gly Thr
Trp Asp Ser Ala
Trp Asp Thr Gly
Trp Glu Gly Ser
Trp Glu Ser Gly
Trp Gly Asp Thr
Trp Gly Glu Ser
Trp Gly Ser Glu
Trp Gly Thr Asp
Trp Ser Ala Asp
Trp Ser Asp Ala
Trp Ser Glu Gly
Trp Ser Gly Glu
Trp Thr Asp Gly
Trp Thr Gly Asp
Batimastat
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors D000970 - Antineoplastic Agents
(3S)-3-[[[(2S)-1-[(2S)-2-[[(4-amino-3-chlorophenyl)-oxomethyl]amino]-3,3-dimethyl-1-oxobutyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-cyanopropanoic acid
2-[2-Oxo-2-[4-(4-phenyl-1-phthalazinyl)-1-piperazinyl]ethyl]isoindole-1,3-dione
N-butan-2-yl-2-[[3-(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)-4-oxo-2-quinazolinyl]thio]acetamide
(1R,9S,10S,11S)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-4-yl-12-(1,3-thiazol-2-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[(2R,3R,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3R,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5S,6R)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5S,6R)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
N-[(2S,3R,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6R)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6S)-6-[2-[[(2,5-difluoroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5R,6S)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5R,6S)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide
(1S,9R,10R,11R)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-4-yl-12-(1,3-thiazol-2-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
Butyl 4,7-DI(para-ethoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine-6-carboxylate
CP-346086
CP-346086 is a potent and orally active microsomal triglyceride transfer protein (MTP) inhibitor, with an IC50 of 2.0 nM for human and rodent MTP. CP-346086 can lower plasma cholesterol and triglycerides in vivo[1].